Bausch Health: brands it owns and its ownership tree
Bausch Health (NYSE: BHC, TSX: BHC) is a publicly listed company headquartered in Laval, Canada that owns 5 consumer brands through 1 subsidiary.[1]
Bausch Health Companies Inc. is a global, diversified specialty pharmaceutical and medical device company, incorporated in British Columbia, with its principal executive offices at 2150 St. Elzéar Blvd. West in Laval, Québec, according to its 2025 Form 10-K. The 10-K lists its common shares on the New York Stock Exchange and the Toronto Stock Exchange under BHC. It says Bausch Health indirectly holds 310,449,643 common shares of Bausch + Lomb, approximately 88% of the issued and outstanding common shares as of February 11, 2026.
Company facts
- Legal name
- Bausch Health Companies Inc. (also BHC)
- Headquarters
- 🇨🇦 Laval, Canada
- Type
- publicly listed company · all publicly listed company owners
- Tickers
- NYSE: BHC TSX: BHC
- Website
- www.bauschhealth.com
- Identifiers
- SEC CIK 0000885590
- Last verified
- · 2 sources
Brands Bausch Health owns
5 brands in 1 category, held directly or through 1 subsidiary.
Devices & animal health (5)
- Biotrue
Medical devices · 🇨🇦 Canada
via Bausch + Lomb
- Lumify
Medical devices · 🇨🇦 Canada
via Bausch + Lomb
- Ocuvite
Medical devices · 🇨🇦 Canada
via Bausch + Lomb
- PreserVision
Medical devices · 🇨🇦 Canada
via Bausch + Lomb
- Stellaris Elite
Medical devices · 🇨🇦 Canada
via Bausch + Lomb
Full list of 5 brands with sources · Interactive ownership tree
Ownership structure
No company is recorded as controlling Bausch Health.
Subsidiaries and holding entities (1)
| Entity | Stake | Jurisdiction | Since | Source |
|---|---|---|---|---|
| Bausch + Lomb Corporation | 88% | Canada | — | [1][2] |
Financials and filings
Bausch Health financial history
Headline figures from Bausch Health's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $8.03bn to $10.3bn, an average of 5.0% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $10.3bn | $1.81bn | 17.7% | $157m | $26.4bn | $20.6bn | 10-K | |
| $9.63bn | $1.55bn | 16.1% | $-46,000,000 | $26.5bn | $18.9bn | 10-K | |
| $8.76bn | $963m | 11.0% | $-592,000,000 | $27.4bn | $21.9bn | 10-K | |
| $8.12bn | $454m | 5.6% | $-225,000,000 | $25.7bn | $20.3bn | 10-K | |
| $8.43bn | $450m | 5.3% | $-948,000,000 | $29.2bn | $22.7bn | 10-K | |
| $8.03bn | $676m | 8.4% | $-560,000,000 | $31.2bn | $23.9bn | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Bausch Health SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers; Regulation FD disclosure | |
| 8-K | Results of a shareholder vote | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Results of operations and financial condition | |
| 8-K | Regulation FD disclosure | |
| 8-K | Results of operations and financial condition; Regulation FD disclosure | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation; Other events | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation |
Bausch Health in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- B3BS7ACMDUWISF18KY76
- Registered name
- BAUSCH HEALTH COMPANIES INC. (CA)
- Registration status
- Issued · record updated 29 June 2026
- Parent
- None named: it reports that no person or entity controls it.
- Retrieved
- · GLEIF record (JSON)
Official recalls involving Bausch Health products
1 recall notice from government regulators matched to Bausch Health. Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
- Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for… — FDA, · Class II
Reason given: Subpotent Drug: Out of specification for assay
Recalling firm: Bausch Health Companies, Inc.
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
What brands does Bausch Health own?
Bausch Health owns 5 consumer brands tracked here, including Stellaris Elite, Lumify, PreserVision, Biotrue and Ocuvite.
Is Bausch Health a Canadian company?
Yes. Bausch Health is headquartered in Laval, Canada.
Who owns Bausch Health?
Bausch Health is a publicly listed company owned by its shareholders; it trades as BHC on the NYSE and BHC on the TSX.
Recent changes to this record
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Bausch Health Companies Inc. Annual Report on Form 10-K filed 2026-02-19 — SEC EDGAR, SEC Form 10-K, published 19 February 2026; retrieved 8 November 2026.
- [2] Bausch + Lomb Corporation Annual Report on Form 10-K filed 2026-02-18 — SEC EDGAR, SEC Form 10-K, published 18 February 2026; retrieved 20 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.